Clinical Trial: Vaginal Progesterone for Treatment of Threatened Miscarriage

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Vaginal Progesterone for Treatment of Threatened Miscarriage; Randomized Clinical Trial

Brief Summary: The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.